This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Autism Investment Conference New York City Feb. 21, 2013

December 21st, 2012

First-ever conference focused exclusively on the opportunity landscape for entrepreneurship, new business development and investment in the autism space.

Autism Speaks, the world's leading autism science and advocacy organization, is hosting the first-ever investment conference focused exclusively a rapidly expanding opportunity landscape for entrepreneurship, new business development and investment. The Autism Investment Conference will be held at the JW Marriott Essex House, 160 Central Park South, New York City, on Thursday, February 21, 2013, 8:00 a.m. – 4:30 p.m. For more information please visit aic.autismspeaks.org

This one-day conference will introduce the diversity of product development areas emerging to address unmet healthcare, education, and services needs of the autism community. This conference will feature expert perspectives and host presentations from companies working in four different areas of new product development; 1) Therapeutic technology (medicines and devices), 2) diagnostics and enabling technology, 3) assistive technology, and 4) services and supports.

More information:
WHAT: Autism Investment Conference

WHERE: JW Marriott Essex House, 160 Central Park South, New York, NY

WHEN: Thursday, February 21, 2013, 8:00 a.m. – 4:30 p.m.

REGISTRATION: Visit aic.autismspeaks.org

SPONSORSHIPS: For sponsorship information contact Robert Ring, Ph.D., Autism Speaks vice president for Translational Research at Robert.Ring@autismspeaks.org

Provided by Autism Speaks

Citation: Autism Investment Conference New York City Feb. 21, 2013 (2012, December 21) retrieved 3 August 2026 from https://sciencex.com/wire-news/117559779/autism-investment-conference-new-york-city-feb-21-2013.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.